
Amaros AI
AI platform turning ophthalmology clinical data into insights for trials, RWE and commercial teams
- Industry
- HealthTech, AI / ML
- Founded
- 2019
- Based in
- United States
Verified revenue: not connected yet
Is Amaros AI yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
Amaros AI builds AmarosEngine, an AI platform for ophthalmology. It combines EMRs, imaging, genetics, provider notes and payer claims into structured insights for clinical trials, real-world evidence and commercial teams. It was founded in 2019 in Silicon Valley, US, and is backed by Armenia-based SmartGate VC.
Team
- Vartan Ghazarossian, Co-founder and CEO (Founder)
- Ben Toker, Co-founder and President (Founder)
Audience
Followers on social networks
Profile data from Stanbase.